Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2023-09-20
DOI
10.1080/08923973.2023.2261146
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MHC Class II Presentation in Autoimmunity
- (2023) Irina A. Ishina et al. Cells
- Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer
- (2022) Chunyan Liu et al. LABORATORY INVESTIGATION
- Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
- (2022) Weina Yu et al. Frontiers in Oncology
- A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
- (2022) Gomaa Mostafa-Hedeab et al. INFLAMMOPHARMACOLOGY
- Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer
- (2022) Maria Gemelli et al. Frontiers in Oncology
- Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing
- (2022) Peng Song et al. Frontiers in Immunology
- Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS / BACH1 axis
- (2022) Tianwei Chen et al. Molecular Oncology
- The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
- (2022) Hebatallah M. Saad et al. Diagnostics
- TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers
- (2021) Qiu-Xian Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival
- (2021) Sen Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade
- (2021) Shengqing Stan Gu et al. Cancer Discovery
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
- (2021) Zhencong Chen et al. Clinical and Translational Medicine
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
- (2021) Stefan C. Dentro et al. CELL
- Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials
- (2021) Thierry Landre et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies
- (2021) L Succony et al. CANCER TREATMENT REVIEWS
- Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer
- (2021) Wei Zhao et al. JNCI-Journal of the National Cancer Institute
- m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
- (2021) Feng Xu et al. Molecular Therapy-Nucleic Acids
- Spotlight on TAP and its vital role in antigen presentation and cross-presentation
- (2021) Ian Mantel et al. MOLECULAR IMMUNOLOGY
- Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
- (2021) Jingyao Tu et al. Theranostics
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
- (2020) Keisuke Yamamoto et al. NATURE
- Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials
- (2020) John P. Thomas et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis
- (2020) Guanbin Qi et al. OncoTargets and Therapy
- MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
- (2020) Annelisa M. Cornel et al. Cancers
- An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles
- (2020) Mengyuan Li et al. Communications Biology
- PTPN6 promotes chemosensitivity of colorectal cancer cells via inhibiting the SP1 / MAPK signalling pathway
- (2020) Huilong Fang et al. CELL BIOCHEMISTRY AND FUNCTION
- CD74, a novel predictor for bronchopulmonary dysplasia in preterm infants
- (2020) Junyan Gao et al. MEDICINE
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
- (2019) Tao Lu et al. Cancer Management and Research
- Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
- (2019) Deborah B Doroshow et al. CLINICAL CANCER RESEARCH
- Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses
- (2019) Ruowen Xiao et al. Translational Cancer Research
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma
- (2019) Chao Zhang et al. Journal of Thoracic Oncology
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- Cancer immune escape: MHC expression in primary tumours versus metastases
- (2019) Federico Garrido et al. IMMUNOLOGY
- Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
- (2019) Chao Huang et al. Frontiers in Oncology
- Mechanisms of Resistance to PD-1 and PD-L1 Blockade
- (2018) Theodore S. Nowicki et al. CANCER JOURNAL
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- The GCTx format and cmap{Py, R, M, J} packages: resources for optimized storage and integrated traversal of annotated dense matrices
- (2018) Oana M Enache et al. BIOINFORMATICS
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- The regulatory network behind MHC class I expression
- (2017) Marlieke L.M. Jongsma et al. MOLECULAR IMMUNOLOGY
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Pentoxifylline Regulates Plasminogen Activator Inhibitor-1 Expression and Protein Kinase A Phosphorylation in Radiation-Induced Lung Fibrosis
- (2017) Jong-Geol Lee et al. Biomed Research International
- GenVisR: Genomic Visualizations in R
- (2016) Zachary L. Skidmore et al. BIOINFORMATICS
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started